HIGHLIGHTS
- who: Naruepon Kampa from the University of Bern, Switzerland have published the article: Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: A prospective, block-randomized, double-blinded, placebo-controlled clinical trial, in the Journal: (JOURNAL)
- what: This study evaluated the effectiveness of glucosamine and chondroitin sulfate, marine based fatty_acid compounds (PCSO-524 and EAB-277), and carprofen for the alleviation of canine hip OA pain. Dogs could exit the study at the discretion of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.